ADIPOQ and metabolic dysfunction-associated steatotic liver disease: Adiponectin levels were higher in subjects with CHC (with and without steatosis) than in those without CHC (NAFLD patients and healthy controls): 9.4 {5.7-13.2} vs. 5.8 {3.9-8.9} μg/ml; p < 0.0001.